The Role of the Manufacturer, Technology, Clinical Practice and Arterial Filtration (Video)
You may also like
Quest Medical, Inc. Issues Recall of MPS® Delivery Set
On October 28, 2015, Quest Medical, Inc. initiated a nationwide recall of Myocardial Protection System (MPS) Delivery Sets, Models 5001102, 5001102-AS, and 7001102 of specified lots. The product(s) have been found to intermittently exhibit a seal failure during use, which potentially could result in patient blood loss.
1 min read
Identification of Modifiable Risk Factors for Acute Kidney Injury after Coronary Artery Bypass Graft Surgery in an Asian Population
We aimed to ascertain whether the lowest hematocrit during CPB, preoperative anemia, and intraoperative transfusion remained as independent modifiable risk factors associated with AKI in our prospective cohort of Asians.
1 min read
Hemoglobin-Driven Pathophysiology is an in Vivo Consequence of the Red Blood Cell Storage Lesion that can be Attenuated in Guinea Pigs by Haptoglobin Therapy
Pathologies observed after transfusion with old blood, together with the favorable response to Hp supplementation, allowed us to define the in vivo consequences of the rbc storage lesion as storage-related posttransfusion hemolysis producing Hb-driven pathophysiology. Hb sequestration by Hp might therefore be a therapeutic modality for enhancing transfusion safety in severely ill or massively transfused patients.
1 min read